Annual report pursuant to Section 13 and 15(d)

Note 3 - Discontinued Operations (Tables)

v3.19.1
Note 3 - Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2018
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   
December 31
,
2018
    
December 31,
2017
  
Accrued liabilities
   $
—
     $
7,092
  
Liabilities associated with discontinued operations, current
   $
—
     $
7,092
  
   
Years Ended December 31,
  
   
2018
    
2017
  
Lymphoseek sales revenue
   $
—
     $
2,917,213
  
Cost of goods sold
    
—
      
364,192
  
Gross profit
    
—
      
2,553,021
  
Operating expenses:
                
Research and development
    
(1,835
)
    
383,446
  
Selling, general and administrative
    
—
      
961,873
  
Total operating expenses
    
(1,835
)
    
1,345,319
  
Income from discontinued operations
    
1,835
      
1,207,702
  
Interest expense
    
—
      
(1,706,491
)
Income (loss) before income taxes
    
1,835
      
(498,789
)
(Provision for) benefit from income taxes
    
(385
)
    
8,031
  
Income (loss) from discontinued operations
   $
1,450
     $
(490,758
)